IRIDEX (IRIX) Form 4 IRIDEX / Partners, L.L.C. BlueLine ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BlueLine Capital Partners, L.P.

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/22/2017		J		600,000	D	$0	1,460,688	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BlueLine Capital Partners, L.P.

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

BlueLine Catalyst Fund IX, L.P.

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

BlueLine Capital Partners II, L.P.

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

BlueLine Capital Partners III, LP

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

BlueLine Partners, L.L.C.

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

BlueLine Partners II, LLC

(Last) (First) (Middle)

3480 BUSKIRK AVENUE

SUITE 214

(Street)

PLEASANT HILL CA 94523

(City) (State) (Zip)

Explanation of Responses:

1. These securities were owned by BlueLine Capital Partners, L.P. On June 22, 2017, BlueLine Capital Partners, L.P. executed an in-kind distribution, without consideration, of 600,000 shares of the Issuer's common stock to certain of its limited partners.

Remarks:

Scott A. Shuda, by power of attorney for all reporting persons. As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities.

	/s/ Scott A. Shuda	06/23/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.